Yan Yuzhong, Kong Nana, Niu Yuxiao, Sun Kangde, Zhang Wenxia
Department of Scientific Research, Shanghai University of Medicine and Health Science Affiliated Zhoupu Hospital, Shanghai, China.
Department of Clinical Laboratory, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Microb Pathog. 2025 Jan;198:107154. doi: 10.1016/j.micpath.2024.107154. Epub 2024 Nov 23.
Hypervirulent and carbapenem-resistant Klebsiella pneumoniae (hv-CRKP) poses a serious threat to public health. Here, we analyse a case of systemic infection caused by a hv-CRKP, which ultimately led to the patient's death from sepsis. And a total of 30 CRKPs were analyzed to elucidate the molecular epidemiological features of CRKPs in the hospital, and to provide a basis for clinical anti-infective therapy.
In this case, a total of 7 K. pneumoniae strains were isolated from the blood, sputum, urine, and feces of the patient. The Vitek-2 compact system was used to identify the strains and perform antimicrobial susceptibility testing. Biofilm formation, siderophore production assays and Galleria mellonella infection model were used to verify the virulence phenotypes of the strains in the case. Whole-genome sequencing was conducted on the four hv-CRKP isolated from different samples in the case and 26 other CRKP collected in our hospital from September to November in 2022, using the Illumina Hiseq 6000 high-throughput sequencing platform to analyse the resistance and virulence genes.
In the case, after 7 days of treatment with ceftazidime-avibactam (CZA), the resistance profile of the strains changed. The strain that was initially sensitive to CZA developed to resistant, resistant to imipenem (IPM) developed to sensitive, and resistant to meropenem (MEM) developed to intermediate. Whole-genome sequencing revealed that the four strains in the case were all ST11-KL64 K. pneumoniae, and the change in resistance phenotype was due to the mutation from bla to bla. KPN7 had a total of six plasmids, with siderophore-related genes iucABCD and iutA, and mucoid phenotype-related gene rmpA2 located on plasmid p4-KPN7; resistance genes bla, bla, and bla located on plasmid p5-KPN7; and virulence genes fim, irp, iutA, and ybt located on the chromosome. Biofilm formation and siderophore production assays confirmed that the seven K. pneumoniae strains isolated in this case had strong biofilm formation and siderophore production capabilities. Galleria mellonella Infection Model showed that KPN4 and KPN7 was phenotypically highly virulent and KPN7 performed lower virulence compared to KPN4. Apart from the 4 hv-CRKP strains, other 26 CRKP strains all carried bla, and 69.2% (18/26) were ST-11 and 30.8%(8/26) were ST-15. And 83.3% (15/18) were ST11-KL64 strains, followed by ST11-KL25 strains 11.1%(2/18) and ST11-KL47 strain 5.6%(1/18). All the eight ST-15 strains were KL-19.
The ST11-KL64 hv-CRKP clone spread widely in ICU carried numerous resistance and virulence genes, and under antibiotic pressure, they easily underwent mutations resulting in changes in resistance phenotypes, especially in mutations of bla gene in acquiring resistance to CZA. Therefore, clinical attention should be paid to such strains, and the use of antibiotics should be adjusted promptly based on the susceptibility of the strains to antimicrobial agents.
高毒力和耐碳青霉烯类肺炎克雷伯菌(hv-CRKP)对公共卫生构成严重威胁。在此,我们分析了一例由hv-CRKP引起的全身感染病例,该病例最终导致患者因败血症死亡。并且共分析了30株CRKP,以阐明医院内CRKP的分子流行病学特征,为临床抗感染治疗提供依据。
在该病例中,从患者的血液、痰液、尿液和粪便中总共分离出7株肺炎克雷伯菌。使用Vitek-2 compact系统对菌株进行鉴定并进行药敏试验。采用生物膜形成、铁载体产生测定和大蜡螟感染模型来验证该病例中菌株的毒力表型。对该病例中从不同样本分离出的4株hv-CRKP以及2022年9月至11月在我院收集的其他26株CRKP进行全基因组测序,使用Illumina Hiseq 6000高通量测序平台分析耐药基因和毒力基因。
在该病例中,用头孢他啶-阿维巴坦(CZA)治疗7天后,菌株的耐药谱发生了变化。最初对CZA敏感的菌株变为耐药,对亚胺培南(IPM)耐药的菌株变为敏感,对美罗培南(MEM)耐药的菌株变为中介。全基因组测序显示该病例中的4株菌株均为ST11-KL64肺炎克雷伯菌,耐药表型的变化是由于bla基因发生了突变。KPN7共有6个质粒,铁载体相关基因iucABCD和iutA以及黏液样表型相关基因rmpA2位于质粒p4-KPN7上;耐药基因bla、bla和bla位于质粒p5-KPN7上;毒力基因fim、irp、iutA和ybt位于染色体上。生物膜形成和铁载体产生测定证实该病例中分离出的7株肺炎克雷伯菌具有很强的生物膜形成和铁载体产生能力。大蜡螟感染模型显示KPN4和KPN7在表型上具有高毒力,且与KPN4相比KPN7的毒力较低。除4株hv-CRKP菌株外,其他26株CRKP菌株均携带bla,69.2%(18/26)为ST-11,30.8%(8/26)为ST-15。并且83.3%(15/18)为ST11-KL64菌株,其次是ST11-KL25菌株11.1%(2/18)和ST11-KL47菌株5.6%(1/18)。所有8株ST-15菌株均为KL-19。
ST11-KL64 hv-CRKP克隆在重症监护病房广泛传播,携带众多耐药和毒力基因,在抗生素压力下,它们容易发生突变导致耐药表型改变,尤其是在获得对CZA耐药性时bla基因的突变。因此,临床应关注此类菌株,并根据菌株对抗菌药物的敏感性及时调整抗生素的使用。